| abstract |
A factor D, a growth hormone, IL-1, is used as well as tumor necrosis factors alone or in combination as synergistic cytoprotective agents for patients exposed to toxic doses of ionizing radiation and / or chemotherapy. Synergistic cytoprotective regimens have been provided which are particularly useful in reducing morbidity and mortality in certain cancer therapies. The invention also relates to the use of a factor D, a growth hormone, tumor necrosis factors, and / or IL-1, alone or in a synergistic combination in the prevention and treatment of alopecia. Factor D is purified by precipitation of contaminating proteins at a strongly acidic pH, and stored stably at said pH. |